🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Investigator's choice of chemotherapy

Found 316 matching trials

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

PHASE3

The main purpose of this study is to compare the disease-free survival betw...

Status

Recruiting

Location

Arkansas Urology

Start Date

2024-04-18

Trial ID

NCT06319820

Treatments Being Tested

TAR-210 Gemcitabine MMC

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

PHASE2

Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...

Status

Terminated

Location

Highlands Oncology Group

Start Date

2014-07

Trial ID

NCT02117024

Treatments Being Tested

Viagenpumatucel-L Metronomic Cyclophosphamide Physician's Choice Regimen (Vinorelbine, Erlotinib, Gemcitabine, Paclitaxel, Docetaxel, Pemetrexed)

Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer

PHASE2

This is a phase II, single arm, multi-centre study to assess the efficacy o...

Status

Active Not Recruiting

Location

Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum

Start Date

2022-02-22

Trial ID

NCT04575961

Treatments Being Tested

Pembrolizumab

Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

PHASE2

To seek the efficacy signals of trastuzumab in combination with chemotherap...

Status

Unknown

Location

Beijing Cancer Hospital

Start Date

2017-07-01

Trial ID

NCT03185988

Treatments Being Tested

chemotherapy in combination with trastuzumab for arm1 chemotherapy in combination with trastuzumab for arm2 chemotherapy in combination with trastuzumab for arm3 chemotherapy in combination with trastuzumab for arm4

Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

PHASE2

This phase II/III trial compares the effect of the combination treatment wi...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2023-03-30

Trial ID

NCT05432791

Treatments Being Tested

Biospecimen Collection Bone Scan Computed Tomography Magnetic Resonance Imaging Multigated Acquisition Scan Olaparib Pazopanib Temozolomide Trabectedin Transthoracic Echocardiography Test

Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression

PHASE2

There have been reports suggesting that continuous administration of epider...

Status

Unknown

Location

Qiong Zhao

Start Date

2013-12

Trial ID

NCT01998061

Treatments Being Tested

EGFR tyrosine kinase inhibitor EGFR tyrosine kinase inhibitor with chemotherapy

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

PHASE2

Urothelial carcinoma (UC) is the ninth most common cancer type worldwide. W...

Status

Active Not Recruiting

Location

Highlands Oncology Group - Springdale /ID# 270290

Start Date

2025-01-20

Trial ID

NCT06632951

Treatments Being Tested

Livmoniplimab Budigalimab Docetaxel Paclitaxel Docetaxel Paclitaxel Gemcitabine

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

PHASE3

The purpose of study is to compare bladder intact-event free survival (BI-E...

Status

Active Not Recruiting

Location

Loma Linda Univ Faculty Medic

Start Date

2020-12-07

Trial ID

NCT04658862

Treatments Being Tested

Cetrelimab TAR-200 Cisplatin Gemcitabine Conventional radiation therapy Hypo-fractioned radiation therapy

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

PHASE3

This is a Phase IIIb, multinational, multicenter, randomized, open-label st...

Status

Completed

Location

Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Start Date

2022-07-05

Trial ID

NCT05415215

Treatments Being Tested

Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)Pertuzumab IV Trastuzumab IV Trastuzumab Emtansine Investigator's Choice of Chemotherapy Surgery Radiotherapy

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

PHASE1

This was an open-label, nonrandomized, Phase 1/2 study designed to determin...

Status

Completed

Location

Mayo Clinic Arizona

Start Date

2017-05-02

Trial ID

NCT03085914

Treatments Being Tested

Epacadostat Pembrolizumab Oxaliplatin Leucovorin 5-Fluorouracil Gemcitabine nab-Paclitaxel Carboplatin Paclitaxel Pemetrexed Cyclophosphamide Carboplatin Cisplatin 5-Fluorouracil Investigator's choice of platinum agent

Previous Next